CN Patent

CN107690281B — 囊性纤维化跨膜转导调节因子调节剂

Assigned to Vertex Pharmaceuticals Inc · Expires 2020-11-17 · 5y expired

What this patent protects

本发明特征在于式(I)的化合物：或其药学上可接受的盐，其中R 1 、R 2 、R 3 、W、X、Y、Z、n、o、p和q如本文所定义，其用于治疗CFTR介导的疾病，例如囊性纤维化。本发明的特征还在于药物组合物，其治疗方法和试剂盒。

USPTO Abstract

本发明特征在于式(I)的化合物：或其药学上可接受的盐，其中R 1 、R 2 、R 3 、W、X、Y、Z、n、o、p和q如本文所定义，其用于治疗CFTR介导的疾病，例如囊性纤维化。本发明的特征还在于药物组合物，其治疗方法和试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number: CN107690281B
Jurisdiction: CN
Classification: —
Expires: 2020-11-17
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.